Navigation Links
Allied Minds Launches Novel Disinfectant/Disinfestant Technology Start-up With UC Davis

Investment Firm, Allied Minds, Establishes New Company to Commercialize

Novel Technology from UC Davis

BOSTON, June 30 /PRNewswire/ -- Allied Minds, a pre-seed investment firm specializing in early stage university business ventures, has established RF Biocidics, Inc., to develop and commercialize a novel disinfectant and disinfestant technology invented at UC Davis.

The newly formed RF Biocidics, Inc. is developing a novel "cleantech" approach using radio frequency (RF) heating to eliminate pathogens and insects without the use of dangerous chemicals or radiation. Traditional efforts to disinfect and disinfest food and agricultural products, have primarily utilized chemical, heat, or radiation inputs with often undesirable results. These methods have inherent problems: 1) toxins are introduced into the food chain and the environment; 2) permanent changes occur in the sensory and nutritional quality of most produce; and 3) radiation drives high the cost of handling and holds a negative consumer perception.

RF heating resolves these issues by delivering lethal energy to insects and microbes without disturbing or damaging the host material or leaving behind any molecules. In general, RF heating eliminates surface heating, reducing thermal loads and allowing a food's quality and nutritional attributes to be maintained. RFB technology is being developed by Professor Manuel Lagunas-Solar of UC Davis.

"We look forward to exploring the many potential applications this technology will encompass. We see benefits in food safety, agriculture, medical sterilization, and as an anti-bioterrorism measure, among others," said Allied Minds COO Marc Eichenberger.

The initial funding for RF Biocidics is being provided by Allied Minds. To learn more about RF Biocidics, please visit .

About Allied Minds, Inc.

Allied Minds is a seed investment company creating partnerships with key universities to fund corporate spinouts resulting from successful early stage technology research. By providing corporate development support as well as finance, Allied Minds aims to guide early stage companies to commercial success, thereby generating value for all stakeholders. For addition information, logon to .

SOURCE Allied Minds, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Four Independent Research Groups Present Data Generated by Pressure Cycling Technology (PCT) at the ASMS Conference on Mass Spectrometry and Allied Topics in Denver, CO
2. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
3. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
4. Glycominds Appoints Board of Directors Chairman
5. Glycominds and Fox Chase Cancer Center Announce a Collaboration to Discover New Cancer Detection Diagnostic Tests
6. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
7. Novozymes Launches Enzyme to Reduce Acrylamide in Food
8. Enova Medical Launches Exos Corporation
9. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
10. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
11. ThirdBiotech Networking Group Launches
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... ... the three Winners and six Finalists of the 2017 Blavatnik Regional Awards for ... Blavatnik Family Foundation and administered by the New York Academy of Sciences to ...
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, ... and biotechnology industries to improve patient outcomes and quality of life, will now ... testing are being attributed to new regulatory requirements for all new drug products, ...
(Date:10/11/2017)... ... ... eye wash is a basic first aid supply for any work environment, but most personal ... rinse first if a dangerous substance enters both eyes? It’s one less decision, and likely ... dual eye piece. , “Whether its dirt and debris, or an acid or alkali, getting ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):